Immunitybio Share Price Today
(NASDAQ: IBRX)

Name: Immunitybio Share Price Today (NASDAQ: IBRX) - Immunitybio Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Immunitybio share price is $2.81 & ₹243.26 as on 19 Mar 2025, 2.30 'hrs' IST

$2.81

▲

-0.1

(-3.44%)

Market is closed - opens 7 PM, 19 Mar 2025

View live Immunitybio share price in Dollar and Rupees. Guide to invest in Immunitybio stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Immunitybio, along with analyst recommendations, forecasts, and comprehensive financials.

Immunitybio share price movements

Today's Low: $2.73
Today's High: $2.83
$2.81
3.02%
Downside
Day's Volatility :3.54%
Upside
0.53%
52 Weeks Low: $2.28
52 Weeks High: $10.53
$2.81
18.86%
Downside
52 Weeks Volatility :78.35%
Upside
73.31%

Immunitybio (IBRX) Returns

Period	Immunitybio Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	6.04%	7.7%	0.0%
6 Months	-17.84%	-5.8%	0.0%
1 Year	-48.25%	0.7%	0.0%
3 Years	-49.91%	7.2%	-15.2%

Immunitybio (IBRX) Key Statistics

in dollars & INR

Previous Close	$2.91
Open	$2.86
Today's High	$2.825
Today's Low	$2.725
Market Capitalization	$2.5B
Today's Volume	$4.1M
52 Week High	$10.53
52 Week Low	$2.28
Revenue TTM	$14.7M
EBITDA	$-326.6M
Earnings Per Share (EPS)	$-0.62
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	0.0%

How to invest in Immunitybio Stock (IBRX) from India?

It is very easy for Indian residents to invest directly in Immunitybio from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Immunitybio stock in both Indian Rupees (INR) and US Dollars (USD). Search for Immunitybio or IBRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Immunitybio or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Immunitybio shares which would translate to 0.308 fractional shares of Immunitybio as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Immunitybio, in just a few clicks!

Returns in Immunitybio (IBRX) for Indian investors in Rupees

The Immunitybio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Immunitybio investment value today

Current value as on today

₹56,076

Returns

₹43,924

(-43.92%)

Returns from Immunitybio Stock

₹48,250 (-48.25%)

Dollar Returns

₹4,326 (+4.33%)

Indian investors sentiment towards Immunitybio (IBRX)

-9.7%

Period: Feb 16, 2025 to Mar 18, 2025. Change in 30 Days versus previous period

Investment in Immunitybio Shares from India has dropped by -9.7% over the past 30 days, indicating reduced transactional activity.

-40%

Period: Feb 16, 2025 to Mar 18, 2025. Change in 30 Days versus previous period

Search interest for Immunitybio Stock from India on INDmoney has decreased by -40% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Immunitybio

Vanguard Group Inc
2.03%
BlackRock Inc
1.59%
State Street Corp
1.15%
Morgan Stanley - Brokerage Accounts
0.47%
Geode Capital Management, LLC
0.45%
Woodline Partners LP
0.40%

Analyst Recommendation on Immunitybio

Buy

75%Buy

25%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Immunitybio(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Immunitybio Stock (IBRX)

What analysts predicted

Upside of 300.36%

Target:

$11.25

Current:

$2.81

Insights on Immunitybio Stock (Ticker Symbol: IBRX)

Price Movement
In the last 1 month, IBRX stock has moved down by -27.9%
Increasing Revenue
Revenue is up for the last 4 quarters, 40.0K → 7.55M (in $), with an average increase of 66.1% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -134.56M → -59.16M (in $), with an average increase of 50.9% per quarter
IBRX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 64.9% return, outperforming this stock by 113.2%
IBRX vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.8% return, outperforming this stock by 100.3%
Price to Sales
ForIBRX every $1 of sales, investors are willing to pay $133.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.9 for every $1 of sales.

Immunitybio Technicals Summary

Sell

Neutral

Buy

Immunitybio is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Immunitybio (IBRX) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Immunitybio Inc.	-16.12%	-17.84%	-48.25%	-49.91%	-91.35%
Regeneron Pharmaceuticals, Inc.	-2.21%	-41.61%	-31.0%	-4.07%	51.66%
Beone Medicines Ltd	9.77%	32.49%	55.49%	45.52%	107.44%
Vertex Pharmaceuticals Incorporated	10.85%	8.03%	23.37%	104.68%	148.66%
Alnylam Pharmaceuticals, Inc.	-2.28%	-10.56%	64.88%	50.4%	135.24%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Immunitybio Inc.	NA	NA	NA	-0.51	0.0	-0.48	NA	-0.57
Regeneron Pharmaceuticals, Inc.	17.7	17.7	1.0	42.64	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.45	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.43	18.06	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.52	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Immunitybio Inc.	Buy	$2.5B	-91.35%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$74.2B	51.66%	17.7	31.07%
Beone Medicines Ltd	NA	$28.4B	107.44%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$131.9B	148.66%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$32.8B	135.24%	NA	-12.37%

Immunitybio Dividend announcements

Immunitybio Earnings
Immunitybio’s price-to-earnings ratio stands at None

About Immunitybio

ImmunityBio, Inc., a vertically-integrated commercial stage biotechnology company, develops next-generation therapies that bolster the natural immune system to defeat cancers and infectious diseases. Its platforms for the development of biologic product candidates include cytokine fusion proteins, vaccine vectors, and cell therapies. The company's platforms have generated nine first-in-human therapeutic agents that are planned to be studied in clinical trials in liquid and solid tumors. Its lead biologic product candidate is Anktiva, an FDA-approved immunotherapy in combination with bacillus calmette-guérin (BCG) for the treatment of adult patients with BCG unresponsive non-muscle invasive bladder cancer with carcinoma in situ, with or without papillary tumors. The company has collaboration agreements with National Cancer Institute; Serum Institute of India Private Limited; and BeiGene, Ltd. The company is based in San Diego, California.

Organization	Immunitybio
Employees	680
CEO	Mr. Richard Gerald Adcock
Industry	Healthcare

Management People of Immunitybio

Name	Title
Dr. Patrick Soon-Shiong F.A.C.S., FRCS (C), M.Sc.	Executive Chairman of the Board and Global Chief Scientific & Medical Officer
Mr. Richard Gerald Adcock	President, CEO & Director
Mr. David C. Sachs	Chief Financial Officer
Dr. Barry J. Simon M.D.	Chief Corporate Affairs Officer & Director
Ms. Regan J. Lauer	Chief Accounting Officer
Dr. Enrique Diloné Ph.D., RAC	Chief Technology Officer
Mr. Jason R. Liljestrom J.D.	General Counsel & Corporate Secretary
Ms. Sarah Singleton	Chief Communications Officer & Head of Patient Advocacy
Dr. Leonard S. Sender M.D.	Chief Medical Officer of Liquid Tumors & Cell Therapy
Dr. Sandeep K. Reddy M.D.	Chief Medical Officer

Important FAQs about investing in IBRX Stock from India :

What is Immunitybio share price today?

Immunitybio share price today stands at $2.81, Open: $2.86 ; Previous Close: $2.91 ; High: $2.83 ; Low: $2.73 ; 52 Week High: $10.53 ; 52 Week Low: $2.28.

The stock opens at $2.86, after a previous close of $2.91. The stock reached a daily high of $2.83 and a low of $2.73, with a 52-week high of $10.53 and a 52-week low of $2.28.

Can Indians buy Immunitybio shares?

Yes, Indians can invest in the Immunitybio (IBRX) from India.

With INDmoney, you can buy Immunitybio at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Immunitybio at zero transaction cost.

How can I buy Immunitybio shares from India?

It is very easy to buy Immunitybio from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Immunitybio (IBRX) be purchased?

Yes, you can buy fractional shares of Immunitybio with INDmoney app.

What are the documents required to start investing in Immunitybio stocks?

To start investing in Immunitybio, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.